Numerous studies have demonstrated a significant correlation between aldehyde dehydrogenase 1 family member a1 (ALDH1A1) expression and various clinicopathological factors in BC, including tumor size, nodal status, histological grade, and BC subtypes.61 This evidence concerns the gene ALDH1A1 and breast cancer.